Indian diagnostics group Dr Lal PathLabs intends to acquire a 70% stake in a pathology company in Madhya Pradesh for up to Rs500m (US$7.2m). In a filing to the Bombay Stock Exchange, Dr Lal said that the acquisition would complete in the next three months. The company, which is still to be established, will be…
©2023 All rights reserved LaingBuisson 
.){kind=link}